28
Views
0
CrossRef citations to date
0
Altmetric
Review

Multidisciplinary Management is Strongly Suggested in Elderly Patients with Rectal Carcinoma

, , , , , & show all
Pages 287-298 | Published online: 02 Jun 2008

Bibliography

  • Jemal A , SiegelR, WardEet al.: Cancer statistics, 2008. CA Cancer J. Clin.58, 78–96(2008).
  • Arveux I , BoutronMC, MriniTEet al.: Colon cancer in the elderly: evidence for a major improvements in health care and survival. Br. J. Cancer76, 963–967(1997).
  • Chang GJ , SkibberJM, FeigBW: Are we undertreating rectal cancer in the elderly?Ann. Surg.246, 215–221(2007).
  • Newcomb PA , CarbonePP: Cancer treatment and age: patient perspectives.J. Natl Cancer Inst.85, 1580–1584(1993).
  • Fentiman IS , TirelliU, MonfardiniSet al.: Cancer in the elderly: why so badly treated? Lancet355, 1020–1022(1990).
  • Monfardini S , LonardiS: Phase II single-agent studies in elderly cancer patients.Tumori88(1 Suppl. 1), S13–S14 (2002).
  • Hutchins LF , UngerJM, CrowleyJJet al.: Underrepresentation of patient 65 years of age or older in cancer treatment trial. N. Engl. J. Med.341, 2061–2067(1999).
  • André T , BoniC, Monnedji-BondiafLet al.: Oxaliplatin, fluorouracil and lencovorin as adjuvant treatment of colon cancer. N. Engl. J. Med.350, 2343–2351(2004).
  • NIH Consensus Conference: Adjuvant therapy for patients with colon and rectal cancer. JAMA264, 1444–1450(1990).
  • Madoff RD : Chemoradiotherapy for rectal cancer – when, why, and how?N. Engl. J. Med.351, 1790–1792(2004).
  • Aschele C , LonardiS: Multidisciplinary treatment of rectal cancer. Medical oncology.Ann. Oncol.18, 1908–1915(2007).
  • Beets-Tan RG , BeetsGL, VliegenRFet al.: Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet357, 497–504(2001).
  • Brown G , RadcliffeAG, NewcombeRGet al.: Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br. J. Surg.90, 355–364(2003).
  • Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. Mercury Study Group. Br. Med. J.333, 779–782(2006).
  • Sauer R , BeckerH, HohenbergerWet al.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl. J. Med.351, 1731–1740(2004).
  • Minsky BD : Adjuvant therapy for rectal cancer. ASCO Annual Meeting Educational Book.J. Clin. Oncol.20, 472–477(2002).
  • Pahlman L : Optimal staging and treatment of localised rectal cancer.Ann. Oncol.13(Suppl. 4), 251–255(2002).
  • Kapiteijn E , Corrie, Marijnem et al.: Preoperative radioterapy combined with total mesorectal excision for resectable rectal cancer. N. Engl. J. Med.345, 638–646(2001).
  • Smalley SR , BenedettiJK, WilliamsonSKet al.: Phase III trial of fluorouracil based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J. Clin. Oncol.24, 3542–3547(2006).
  • Tirelli U , MonfardiniS: Treatment of elderly patients with antineoplastic chemotherapy.J. Clin. Oncol.13, 1282–1283(1995).
  • Yancik R , RiesLA: Cancer in older persons: magnitude of the problem: how do we apply what we know?Cancer74(7 Suppl.), 1995–2003(1994).
  • Monfardini S , FerrucciL, FratinoLet al.: Validation of a multidimensional evaluation scale for use in elderly cancer patients. Cancer77, 395–501(1996).
  • Monfardini S , BalducciL: A Comprehensive Geriatric Assessment (CGA) is necessary for the study and the management of cancer in the elderly.Eur. J. Cancer35, 1771–1772(1999).
  • Repetto L , FratinoL, AudisioRAet al.: Comprehensive Geriatric Assessment adds information to Eastern Cooperative Oncology Group Performance status in elderly cancer patients: an Italian group for geriatric oncology study. J. Clin. Oncol.20, 494–502(2002).
  • Balducci L , YatesJ: General guidelines for the management of older patients with cancer.Oncology (Williston Park)14, 221–227(2000).
  • Colorectal Cancer Collaborative Group: Surgery for colorectal cancer in elderly patients: a systematic review. Lancet356, 968–974(2000).
  • Clark AJ , StocktonD, ElderAet al.: Assessment of outcomes after colorectal cancer resection in the elderly as a rationale for screening and early detection. Br. J. Surg.91, 1345–1351(2004).
  • Fietkau R , ZettlH, KlockingSet al.: Incidence, therapy and prognosis of colorectal cancer in different age groups: a population-based cohort study of the Rostock Cancer Registry. Strahlenther. Onkol.180, 478–487(2004).
  • Vercelli M , CapocacciaR, QuagliaAet al.: Relative survival in elderly European cancer patients: evidence for health care inequalities. The EUROCARE Working Group. Crit. Rev. Oncol. Hematol35, 161–179(2000).
  • Cohen SM , NeugutAI: Adjuvant therapy for rectal cancer in the elderly.Drugs Aging21, 437–451(2004).
  • Curless R , FrenchJM, WilliamsGVet al.: Colorectal carcinoma: do elderly patients present differently. Age Ageing23, 102–107(1994).
  • Endreseth BH , RomundstadP, MyrvoldHEet al.: Rectal cancer treatment of the elderly. Colorectal Dis.8, 471–470(2006).
  • Enzinger PC , MayerRJ: Gastrointestinal cancer in older patients.Semin. Oncol.31, 206–219(2004).
  • Smith JJ , LeeJ, BurkeC, ContractorKB, DawsonPM: Major colorectal cancer resection should not be denied to the elderly.Eur. J. Surg. Oncol.28, 661–666(2002).
  • Law WL , ChoiHK, HoJWCet al.: Outcomes of surgery for mid and distal rectal cancer in the elderly. World J. Surg.30, 598–604(2006).
  • Ho P , LawWL, ChanSCet al.: Functional outcome following low anterior resection with total mesorectal excision in the elderly. Int. J. Colorectal Dis.18, 230–233(2003).
  • Phillips PS , FarquharsonSM, SextonRet al.: Rectal cancer in the elderly: patients’ perception of bowel control after restorative surgery. Dis. Colon Rectum47, 287–290(2004).
  • Wagman RT , MinskyBD: Conservative management of rectal cancer with local excision and adjuvant therapy.Oncology15, 513–519(2001).
  • Mellgren A , SirivongsP, RothenbergerDAet al.: Is local excision adequate therapy for early rectal cancer? Dis. Colon Rectum.43, 1064–1071; discussion 1071–1074 (2000).
  • Engstrom PF , BensonAB 3rd, Chen YJ et al.: Rectal cancer clinical practice guidelines in oncology. J. Natl Compr. Canc. Netw.3, 492–508(2005).
  • Rutten HJ , Den Dulk M, Lemmens VE et al.: Rectal cancer treatment in the elderly. Eur. J. Cancer43, 2295–2300(2007).
  • Ratto C , RicciR, ValentiniVet al.: Neoplastic mesorectal microfoci (MMF) following neoadjuvant chemoradiotherapy: clinical and prognostic implications. Ann. Surg. Oncol.14, 853–861(2007).
  • Camma C , GiuntaM, FioricaFet al.: Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA284, 1008–1015(2000).
  • Schrag D , GelfandSE, BachPBet al.: Who gets adjuvant treatment for stage II and III rectal cancer? Insight from Surveillance, Epidemiology, and End Results–Medicare. J. Clin. Oncol.19, 3712–3718(2001).
  • Phelip JM , MilanC, HerbertCet al.: Evaluation of the management of rectal cancers before and after the consensus conference in France. Eur. J. Gastroenterol. Hepatol.16, 1003–1009(2004).
  • Phelip JM , LaunoyG, ColonnaMet al.: Regional variations in management of rectal cancer in France. Gastroenterol. Clin. Biol.28, 378–383(2004).
  • Baxter NN , RothenbergerDA, MorrisAM, BullardKM: Adjuvant radiation for rectal cancer: do we measure up to the standard of care? An epidemiologic analysis of trends over 25 years in the United States.Dis. Colon Rectum48, 9–15(2005).
  • Ayanian JZ , ZaslavskyAM, FuchsCSet al.: Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J. Clin. Oncol.21, 1293–300(2003).
  • Bouvier AM , LaunoyG, LepageC, FaivreJ: Trends in the management and survival of digestive tract cancers among patients aged over 80 years.Aliment. Pharmacol. Ther.22, 233–241(2005).
  • Lorchel F , PeignauxK, CréhangeG: Preoperative radiotherapy in elderly patients with rectal cancer.Gastroenterol. Clin. Biol.31, 436–441(2007).
  • Pignon T , HoriotJC, BollaMet al.: Age is not a limiting factor for radical radiotherapy in pelvic malignancies. Radiother. Oncol.42, 107–120(1997).
  • Kiyomatsu T , WatanabeT, TsuritaG, KomuroY, NagawaN: Preoperative radiotherapy for advanced rectal cancer in the elderly. Presented at: 15th World Congress of the International Association of Surgeons and Gastroenterologists. Prague, Czech Republic, 15–20 October, 52, A179 (2005).
  • Dharma-Wardene MW , de Gara C, Au HJ et al.: Ageism in rectal carcinoma? Treatment and outcome variations. Int. J. Gastrointest. Cancer32, 129–138(2002).
  • Neugut AI , FleischauerAT, SundararajanVet al.: Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J. Clin. Oncol.20, 2643–2650(2002).
  • Watanabe T , KiyomatsuT, NagawaH: Management of rectal cancer – is adjuvant radiotherapy safe for the elderly?Aliment. Pharmacol. Ther.22, 1164–1165(2005).
  • Tepper JE , O‘ConnellM, NiedwieckiDet al.: Adjuvant therapy in rectal caner: analysis of stage, sex, and local control – final report of Intergroup 0114. J. Clin. Oncol.20, 1744–1750(2002).
  • Gunderson LL , SargentDJ, TepperJEet al.: Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J. Clin. Oncol.22, 1785–1796(2004).
  • Gérard JP , GinotA, ArefpourAet al.: Rectal adenocarcinoma in patients aged 80 years or more: towards conservative treatment. American Society for Therapeutic Radiology and Oncology (ASTRO). Int. J. Radiat. Oncol. Biol. Phys.66(Suppl. 1) S311 (Abstract 2183) (2006).
  • Gérard JP , ChapetO, OrtholanCet al.: French experience with contact x-ray endocavitary radiation for early rectal cancer. Clin. Oncol.19, 661–673(2007).
  • Sargent DJ , GoldbergRM, JacobsonSDet al.: A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N. Engl. J. Med.345, 1091–1097(2001).
  • GastroIntestinal Tumor Study Group: Prolongation of disease free interval in surgically treated rectal carcinoma. N. Engl. J. Med.312, 1465–1472(1985).
  • Douglass HO , MoertelCG, MayerRJet al.: Survival after post operative combination treatment of rectal cancer. N. Engl. J. Med.35, 1294–1295(1986).
  • Krook JE , MoertelCG, GundersonLLet al.: Effective surgical adjuvant therapy for high-risk rectal carcinoma. N. Engl. J. Med.324, 709–715(1991).
  • Tveit KN , GuldvogI, HagenSet al.: Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Br. J. Surg.84, 1130–1135(1997).
  • Bosset JF , ColletteL, CalaisGet al.: Chemotherapy with preoperative radiotherapy in rectal cancer. N. Engl. J. Med.355, 1114–1123(2006).
  • Gerard JP , ConroyT, BonnetainFet al.: Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203. J. Clin. Oncol.24, 4620–4629(2006).
  • Dobie SA , WarrenJL, MatthewsBet al.: Survival benefit and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population. Cancer112, 789–799(2008).
  • Schroen AT , CressRD: Use of surgical procedures and adjuvant therapy in rectal cancer treatment: a population based study.Ann. Surg.234, 641–51(2001)
  • Kohne CH , GrotheyA, BokemeyerCet al.: Chemotherapy in elderly patients with colorectal cancer. Ann. Oncol.12, 435–442(2001).
  • Rich TA , ShepardRC, MosleyST: Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy.J. Clin. Oncol.22, 2214–2232(2004).
  • Hartley A , HoKF, McConkeyC, GehJI: Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of Phase II/III trials.Br. J. Radiol.78, 934–93(2005).
  • Glimelius B : Chemoradiotherapy for rectal cancer – is there an optimal combination?Ann. Oncol.12, 1039–1015(2001).
  • Lonardi S , BortolamiA, StefaniMet al.: Oral anticancer drugs in the elderly: an overview. Drugs Aging24(5), 395–410(2007).
  • Cascini GL , AvalloneA, DelrioPet al.: 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J. Nucl. Med.47, 1241–1248(2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.